Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 03 Sept 2025 for Spero Therapeutics, Inc., €11k. Read the official filing
Filing timeline
BuySaleAnkit Mahadevia
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ankit Mahadevia: trading record in brief
Ankit Mahadevia (chief executive) discloses dealings in Spero Therapeutics, Inc. to SEC (Form 4). We count 13 filings; the first trade dates from 26 August 2021 and the latest from 28 August 2025.
Every open-market trade on record is a sale: 6 sales worth €140k. Other entries cover 6 share grants and 1 option exercise. So far in 2025, the count stands at no purchases and 2 sales.
The record was last updated on 3 September 2025 with an open-market sale (€11k) in Spero Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ankit Mahadevia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
6,572 shares@ US$1.976.1% of flowCommon StockSEC:0000950170-25-112661:0
20,000 shares0Common StockSEC:0000950170-25-087021:0
13,959 shares@ US$0.784.9% of flowCommon StockSEC:0000950170-25-014849:0
5,912 shares@ US$1.353.4% of flowCommon StockSEC:0000950170-24-102000:0
20,000 shares0Common StockSEC:0000950170-24-066625:0
63,795 shares@ US$1.3737.9% of flowCommon StockSEC:0000950170-24-011496:0
20,000 shares0Common StockSEC:0000950170-23-052692:0
9,040 shares@ US$1.265.0% of flowCommon StockSEC:0000950170-23-045442:0
12,286 shares@ US$1.819.6% of flowCommon StockSEC:0000899243-23-004039:0
531,914 shares0Common StockSEC:0000899243-23-003939:0
134,168 shares0Common StockSEC:0000899243-22-004591:0
8,000 shares@ US$5.9022.9% of flowCommon StockSEC:0000899243-21-050049:0
78,219 shares0Common StockSEC:0000899243-21-034502:0
13 of 13 declarations
